Mixed Connective Tissue Disease
11
3
4
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
1 terminated out of 11 trials
83.3%
-3.2% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
Rheumatology Patient Registry and Biorepository
Creating Health Course Study for People With Rheumatological Conditions
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
New Orleans Pulmonary Hypertension Biobank
Yellow Fever Vaccine in Patients With Rheumatic Diseases
CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study
The CARRA Registry
Role of Mesenchymal Stem Cells in Fat Grafting